Publications:

First-in-Human, Phase 1 Dose-Escalation Study of Biparatopic Anti-HER2 Antibody-Drug Conjugate MEDI4276 in Patients with HER2-positive Advanced Breast or Gastric Cancer.

Molecular Cancer Therapeutics

Pegram, Mark D MD; Hamilton, Erika P EP; Tan, Antoinette R AR; Storniolo, Anna Maria AM; Balic, Kemal K; Rosenbaum, Anton I AI; Liang, Meina M; He, Peng P; Marshall, Shannon S; Scheuber, Anita A; Das, Mayukh M; Patel, Manish R MR

Publication Date: 2021-08

Variant appearance in text: PIK3CA: L234F

PubMed Link: 34045233

Variant Present in the following documents:

• Main text
• 1442.pdf

View BVdb publication page

A direct role for SNX9 in the biogenesis of filopodia.

The Journal Of Cell Biology

Jarsch, Iris K IK; Gadsby, Jonathan R JR; Nuccitelli, Annalisa A; Mason, Julia J; Shimo, Hanae H; Pilloux, Ludovic L; Marzook, Bishara B; Mulvey, Claire M CM; Dobramysl, Ulrich U; Bradshaw, Charles R CR; Lilley, Kathryn S KS; Hayward, Richard D RD; Vaughan, Tristan J TJ; Dobson, Claire L CL; Gallop, Jennifer L JL

Publication Date: 2020-04-06

Variant appearance in text: PI3K: L234F

PubMed Link: 32328641

Variant Present in the following documents:

• Main text
• JCB_201909178.pdf

View BVdb publication page